focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
You seem highly astute, wise and intelligent. It's so obvious. I, on the other hand, a mere mortal.
So, forgive me for asking, O Wise One, but why is repacking generic products at a premium price, whilst entering one of the most crowded and competitive markets without any brand equity or marketing investment (worthy of that name), an intelligent endeavour?
for those who still think CBX has anything remotely unique....lol!
N-O-T.!
Most reviews are managed somehow
agreed. Equity raise is unavoidable
No, no, no my friend....they are not spending it on sign marketing investments....you read my post all wrong: whatI am saying is that:
1) Cash burn was higher by end Nov, than even Ad-Naseam-the-wise predicted
2) since then, they have hired an CEO (additional cost), and she has told us that they are hiring a marketing and sales director on top. This is not knowing what else they are doing....so suffice to say that the cash burn since Dec has only accelerated
So, I hear you say:"what did CBX do to off-set that since Dec:
1) They delayed the launch, meaning no revenues whilst having extra cost
2) A failed launched
3) Meaning: less marketing £/$ left to invest to grow demand.
So: this business is fundamentally ill, and going down the drains, as there as hardly any marketing £/$ to grow the business.
next step: big equity raise to fund the lavish salaries of a bunch of spoiled execs-without-skin-in-the-game.
*except
I remain amazed at how "liberal" people are on here with facts...."they have 10mn in cash"....no they do not!!
They have 7mn and change. Cash burn is higher than even The Mother of all Rampers, Ad-nauseam, expected!
Btw that is one of the issues: they keep increasing there cash burn levels (new CEO, extra marketing and sales staff etc)....meaning cash burn will only increase....there will be little money left for any marketing efforts.
Note to Ad Nauseam: it doesn't matter whether you calculate the marketing budget in £, $, € or zloty's. F# all is f#all, regardless of currency (expect in the mind of Ad Nauseam)
what you seem to fail to understand (or deliberately ignore to fool potential new investors) is that any other company can buy exactly the same serum and launch it tomorrow.
Given CBX has hardly any marketing budget, it is extremely likely that when another company launches the same product they will have (far) bigger marketing budgets and blow CBX's launch out of the water.
Why can't you at least me honest about this? Why do you have to dress it up ? Why are you trying to make it better than what it is?
You are never capable of providing any answers to any serious concerns or business challenges that are raised here. You simply default to the unintelligent one liners calling people shorters. Btw, I wish I had shorted this stock, I would have made a killing!
I raise sensible concerns and challenges to point out short comings in the current business strategy of CBX, you seem to content yourself with fooling people. Not very nice, sir!
"This is the first and only serum in the UK that contains CBG (cannabigerol)," => given they repackage products that "advantage" will last until someone else launched the same (if not done already)
As to the benefit claims you make: these are must soften on their own website, meaning your claim can not be substantiated and therefore not be made in marketing communications. So, you may think these benefit claims are true but if they cannot shout them from the rooftops than they have very limited use.
what does my perceived nationality matter? Since when is this a criteria for a sound POV? You have not been able to rebuttal one ounce of criticism I have made. Lots of posters seem to agree btw, judging by their criticism.
Let me remind you:
My PoV: no USP. What is your rebuttal?
No significant amount of marketing $: what is your rebuttal?
Cash running out quickly/equity raise a matter of time. What is your rebuttal?
Failed strategy: entering a super competitive market place, going up against major FMCG players, without the marketing muscle to fight. Like bringing a knife to a gun fight. What is your rebuttal?
Please provide sensible answers if at all possible. Just facts, no personal insults (if that is at all weighing your means)
honestly, you have zero USP, no brand and no marketing $. Why on earth do you think this nee CEO could do anything? All she ever did in previous roles was working on very big established brands with USPs and with massive amount of marketing $....this is a very different ballgame!
careful, some here will start swearing at you. No doubt you will be branded a shorter. Having said that I totally agree with you on all counts.
I also feel that their overall strategy is wrong: they want to turn this in a beauty brand, which is such a crowded space where you need a massive amount of marketing dollars; more than this company will ever be able to afford.
"Repackaging generic products and selling them at a premium price in a market place where they cannot compete", pretty much sums it up to me.
They totally hired the wrong CEO-profile, I think you need someone who will establish a brand build on a strong USP that commands premium pricing. I would more look towards healthcare than beauty. As soon as you have your core technology established with the right healthcare credentials you can than stretch your equity to wellness and beauty but only once consumer believe that you have something unique to offer.
(it's not because Beckham spent a tiny amount of his wealth that this will automatically fly)
I am curious: what is unique about it?
is this Serum product unique in any way, do you know? Or also a "repackaged product "?
too many typos
like I said: to get to the bottom of weather this is a good potential investment. So my take out is that we are talking about repackaged generic products, premium priced, without marketing $, no brand equity, no strategy and a failed launch. And cash burn that is higher than even you expected. I am willing to be the optimist here but what is there exactly to like here?
like I said: to get to the bottom of weather this is a good potential investment. So my take out is that we are taking about repackaged generic products, premium priced, with marketing $, no brand equity, no strategy and a failed launch. And cash burn that is higher than even you expected. I am willing to be the optimist here but what is there exactly to like here?
no doubt Ad-Meliora will claim the article was written by a shorter!
won't go bust - this is AIM...it will be equity raise after equity raise
yes, and the future doesn't look too bright either:
- no marketing dollars worth mentioning
- website looks terrible
- no marketing muscle
- and a lineup of generic repackaged products
Good luck with that!
Launching on Amazon now is an act of desperation: people buy products on Amazon that they now off. It's not a channel to grow a brand from scratch. Makes no sense, they should build a proper e-commerce line-up and a range with proper USPs